Cytokines: Their role in stroke and potential use as biomarkers and therapeutic targets

Aging and Disease

Volumn 5, Issue 5, 2014, Pages 294-306

  Doll, Danielle N ^a   Barr, Taura L ^c,d   Simpkins, James W ^b,d  

^a Sensory Neuroscience Research Center   (United States)

^b WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c School of Nursing   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Biomarkers; Cytokines; Stroke

Indexed keywords

EID: 84916881591     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0500294     Document Type: Review

References (99)

1. American Heart Association (2012). About Stroke. http://www.strokeassociation.org/STROKEORG/
2. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Hernandez AF, Peterson ED, et al. (2011). Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiative. Stroke; a journal of cerebral circulation, 42: 2983-2989
3. Davies CA, Loddick SA, Toulmond S, Stroemer RP, Hunt J, Rothwell NJ (1999). The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 19: 87-98
4. Zheng Z, Yenari MA (2004). Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurological research, 26: 884-892
5. Danton GH, Dietrich WD (2003). Inflammatory mechanisms after ischemia and stroke. Journal of neuropathology and experimental neurology, 62: 127-136
6. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, et al. (1994). Tumor necrosis factor-alpha expression in ischemic neurons. Stroke; a journal of cerebral circulation, 25: 1481-1488
7. del Zoppo GJ (2006). Stroke and neurovascular protection. The New England journal of medicine, 354: 553-555
8. Dirnagl U, Iadecola C, Moskowitz MA (1999). Pathobiology of ischaemic stroke: an integrated view. Trends in neurosciences, 22: 391-397
9. Hossmann KA (1996). Periinfarct depolarizations. Cerebrovascular and brain metabolism reviews, 8: 195-208
10. Coyle JT, Puttfarcken P (1993). Oxidative stress, glutamate, and neurodegenerative disorders. Science (New York, N.Y.), 262: 689-695
11. Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M, Pedata F (2005). ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochemistry international, 47: 442-448
12. Schock SC, Munyao N, Yakubchyk Y, Sabourin LA, Hakim AM, Ventureyra EC, et al. (2007). Cortical spreading depression releases ATP into the extracellular space and purinergic receptor activation contributes to the induction of ischemic tolerance. Brain research, 1168: 129-138
13. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, Jung S, et al. (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nature neuroscience, 8: 752-758
14. Cardenas A, Moro MA, Leza JC, O'Shea E, Davalos A, Castillo J, et al. (2002). Upregulation of TACE/ADAM17 after ischemic preconditioning is involved in brain tolerance. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 22: 1297-1302
15. Tang SC, Arumugam TV, Xu X, Cheng A, Mughal MR, Jo DG, et al. (2007). Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits. Proceedings of the National Academy of Sciences of the United States of America, 104: 13798-13803
16. Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, et al. (2009). Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. The Journal of neuroscience: the official journal of the Society for Neuroscience, 29: 9839-9849
17. Matsumoto H, Kumon Y, Watanabe H, Ohnishi T, Takahashi H, Imai Y, et al. (2007). Expression of CD200 by macrophage-like cells in ischemic core of rat brain after transient middle cerebral artery occlusion. Neuroscience letters, 418: 44-48
18. Baeuerle PA, Henkel T (1994). Function and activation of NF-kappa B in the immune system. Annual review of immunology, 12: 141-179
19. Bargatze RF, Kurk S, Butcher EC, Jutila MA (1994). Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. The Journal of experimental medicine, 180: 1785-1792
20. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, et al. (1999). Increased cytokine release from peripheral blood cells after acute stroke. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 19: 1004-1009
21. Vila N, Castillo J, Davalos A, Esteve A, Planas AM, Chamorro A (2003). Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke; a journal of cerebral circulation, 34: 671-675
22. Liu ZG, Hsu H, Goeddel DV, Karin M (1996). Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell, 87: 565-576
23. Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL, Lenardo MJ (2000). A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science (New York, N.Y.), 288: 2351-2354
24. Gourin CG, Shackford SR (1997). Production of tumor necrosis factor-alpha and interleukin-1beta by human cerebral microvascular endothelium after percussive trauma. The Journal of trauma, 42: 1101-1107
25. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997). TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 17: 483-490
26. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, et al. (2009). Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. The Journal of neuroscience: the official journal of the Society for Neuroscience, 29: 1319-1330
27. Nawashiro H, Martin D, Hallenbeck JM (1997). Inhibition of tumor necrosis factor and amelioration of brain infarction in mice. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 17: 229-232
28. Nawashiro H, Martin D, Hallenbeck JM (1997). Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain research, 778: 265-271
29. Yang GY, Gong C, Qin Z, Liu XH, Lorris Betz A (1999). Tumor necrosis factor alpha expression produces increased blood-brain barrier permeability following temporary focal cerebral ischemia in mice. Brain research. Molecular brain research, 69: 135-143
30. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, et al. (1997). Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke; a journal of cerebral circulation, 28: 1233-1244
31. Dawson DA, Martin D, Hallenbeck JM (1996). Inhibition of tumor necrosis factor-alpha reduces focal cerebral ischemic injury in the spontaneously hypertensive rat. Neuroscience letters, 218: 41-44
32. Lavine SD, Hofman FM, Zlokovic BV (1998). Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 18: 52-58
33. Buttini M, Appel K, Sauter A, Gebicke-Haerter PJ, Boddeke HW (1996). Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience, 71: 1-16
34. Gregersen R, Lambertsen K, Finsen B (2000). Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 20: 53-65
35. Lambertsen KL, Gregersen R, Finsen B (2002). Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 22: 785-797
36. Dziewulska D, Mossakowski MJ (2003). Cellular expression of tumor necrosis factor a and its receptors in human ischemic stroke. Clinical neuropathology, 22: 35-40
37. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, et al. (1997). Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clinical and experimental immunology, 110: 492-499
38. Sairanen T, Carpen O, Karjalainen-Lindsberg ML, Paetau A, Turpeinen U, Kaste M, et al. (2001). Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke; a journal of cerebral circulation, 32: 1750-1758
39. Vila N, Castillo J, Davalos A, Chamorro A (2000). Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke; a journal of cerebral circulation, 31: 2325-2329
40. Zaremba J, Losy J (2001). Early TNF-alpha levels correlate with ischaemic stroke severity. Acta neurologica Scandinavica, 104: 288-295
41. Montaner J, Rovira A, Molina CA, Arenillas JF, Ribo M, Chacon P, et al. (2003). Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 23: 1403-1407
42. Ormstad H, Aass HC, Lund-Sorensen N, Amthor KF, Sandvik L (2011). Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. Journal of neurology, 258: 677-685
43. Fassbender K, Schmidt R, Mossner R, Daffertshofer M, Hennerici M (1994). Pattern of activation of the hypothalamic-pituitary-adrenal axis in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke; a journal of cerebral circulation, 25: 1105-1108
44. Intiso D, Stampatore P, Zarrelli MM, Guerra GL, Arpaia G, Simone P, et al. (2003). Incidence of first-ever ischemic and hemorrhagic stroke in a well-defined community of southern Italy, 1993-1995. European journal of neurology: the official journal of the European Federation of Neurological Societies, 10: 559-565
45. Castellanos M, Castillo J, Garcia MM, Leira R, Serena J, Chamorro A, et al. (2002). Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target. Stroke; a journal of cerebral circulation, 33: 982-987
46. Thornberry NA, Bull HG, Calaycay JR, Chapman KT, Howard AD, Kostura MJ, et al. (1992). A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature, 356: 768-774
47. Korherr C, Hofmeister R, Wesche H, Falk W (1997). A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. European journal of immunology, 27: 262-267
48. Allan SM, Tyrrell PJ, Rothwell NJ (2005). Interleukin-1 and neuronal injury. Nature reviews. Immunology, 5: 629-640
49. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, et al. (2003). Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. The Journal of neuroscience: the official journal of the Society for Neuroscience, 23: 8692-8700
50. Bernardes-Silva M, Anthony DC, Issekutz AC, Perry VH (2001). Recruitment of neutrophils across the blood-brain barrier: the role of E- and P-selectins. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 21: 1115-1124
51. Konsman JP, Vigues S, Mackerlova L, Bristow A, Blomqvist A (2004). Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. The Journal of comparative neurology, 472: 113-129
52. Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Floridi A, et al. (2004). Different cytokine levels in thrombolysis patients as predictors for clinical outcome. European journal of neurology: the official journal of the European Federation of Neurological Societies, 11: 377-381
53. Hara H, Fink K, Endres M, Friedlander RM, Gagliardini V, Yuan J, et al. (1997). Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 17: 370-375
54. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, et al. (1997). Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proceedings of the National Academy of Sciences of the United States of America, 94: 2007-2012
55. Ohtaki H, Takaki A, Yin L, Dohi K, Nakamachi T, Matsunaga M, et al. (2003). Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice. Acta neurochirurgica. Supplement, 86: 191-194
56. Garcia JH, Liu KF, Relton JK (1995). Interleukin-1 receptor antagonist decreases the number of necrotic neurons in rats with middle cerebral artery occlusion. The American journal of pathology, 147: 1477-1486
57. Loddick SA, Rothwell NJ (1996). Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 16: 932-940
58. Relton JK, Martin D, Thompson RC, Russell DA (1996). Peripheral administration of Interleukin-1 Receptor antagonist inhibits brain damage after focal cerebral ischemia in the rat. Experimental neurology, 138: 206-213
59. Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K (1995). Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke; a journal of cerebral circulation, 26: 676-680; discussion 681
60. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B (2008). Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. Journal of neuroinflammation, 5: 46
61. Hill JK, Gunion-Rinker L, Kulhanek D, Lessov N, Kim S, Clark WM, et al. (1999). Temporal modulation of cytokine expression following focal cerebral ischemia in mice. Brain research, 820: 45-54
62. Berti R, Williams AJ, Moffett JR, Hale SL, Velarde LC, Elliott PJ, et al. (2002). Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 22: 1068-1079
63. Wang X, Yue TL, Barone FC, White RF, Gagnon RC, Feuerstein GZ (1994). Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid, 23: 103-114
64. Liu T, McDonnell PC, Young PR, White RF, Siren AL, Hallenbeck JM, et al. (1993). Interleukin-1 beta mRNA expression in ischemic rat cortex. Stroke; a journal of cerebral circulation, 24: 1746-1750; discussion 1750-1741
65. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, et al. (1995). Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke; a journal of cerebral circulation, 26: 1393-1398
66. Beridze M, Sanikidze T, Shakarishvili R, Intskirveli N, Bornstein NM (2011). Selected acute phase CSF factors in ischemic stroke: findings and prognostic value. BMC neurology, 11: 41
67. Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, et al. (2006). Inflammatory biomarkers in blood of patients with acute brain ischemia. European journal of neurology: the official journal of the European Federation of Neurological Societies, 13: 505-513
68. Emsley HC, Smith CJ, Gavin CM, Georgiou RF, Vail A, Barberan EM, et al. (2007). Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC neurology, 7: 5
69. Erta M, Quintana A, Hidalgo J (2012). Interleukin-6, a major cytokine in the central nervous system. International journal of biological sciences, 8: 1254-1266
70. Saito M, Yoshida K, Hibi M, Taga T, Kishimoto T (1992). Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. Journal of immunology (Baltimore, Md.: 1950), 148: 4066-4071
71. Hakkoum D, Stoppini L, Muller D (2007). Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. Journal of neurochemistry, 100: 747-757
72. Tancredi V, D'Antuono M, Cafe C, Giovedi S, Bue MC, D'Arcangelo G, et al. (2000). The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. Journal of neurochemistry, 75: 634-643
73. Marz P, Gadient RA, Otten U (1996). Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha). Brain research, 706: 71-79
74. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, et al. (1995). Fever in acute stroke worsens prognosis. A prospective study. Stroke; a journal of cerebral circulation, 26: 2040-2043
75. Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, et al. (2000). Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke; a journal of cerebral circulation, 31: 1715-1720
76. Herrmann O, Tarabin V, Suzuki S, Attigah N, Coserea I, Schneider A, et al. (2003). Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 23: 406-415
77. Loddick SA, Turnbull AV, Rothwell NJ (1998). Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 18: 176-179
78. Suzuki S, Tanaka K, Nogawa S, Nagata E, Ito D, Dembo T, et al. (1999). Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 19: 1256-1262
79. Wang X, Yue TL, Young PR, Barone FC, Feuerstein GZ (1995). Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 15: 166-171
80. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V (2001). Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 22: 289-296
81. Waje-Andreassen U, Krakenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J, et al. (2005). IL-6: an early marker for outcome in acute ischemic stroke. Acta neurologica Scandinavica, 111: 360-365
82. Krause CD, Mei E, Xie J, Jia Y, Bopp MA, Hochstrasser RM, et al. (2002). Seeing the light: preassembly and ligand-induced changes of the interferon gamma receptor complex in cells. Molecular & cellular proteomics: MCP, 1: 805-815
83. Kotenko SV, Izotova LS, Pollack BP, Muthukumaran G, Paukku K, Silvennoinen O, et al. (1996). Other kinases can substitute for Jak2 in signal transduction by interferon-gamma. The Journal of biological chemistry, 271: 17174-17182
84. Finbloom DS, Winestock KD (1995). IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. Journal of immunology (Baltimore, Md.: 1950), 155: 1079-1090
85. Ooboshi H, Ibayashi S, Shichita T, Kumai Y, Takada J, Ago T, et al. (2005). Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation, 111: 913-919
86. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S, et al. (2009). Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature medicine, 15: 192-199
87. Spera PA, Ellison JA, Feuerstein GZ, Barone FC (1998). IL-10 reduces rat brain injury following focal stroke. Neuroscience letters, 251: 189-192
88. de Bilbao F, Arsenijevic D, Moll T, Garcia-Gabay I, Vallet P, Langhans W, et al. (2009). In vivo over-expression of interleukin-10 increases resistance to focal brain ischemia in mice. Journal of neurochemistry, 110: 12-22
89. Grilli M, Barbieri I, Basudev H, Brusa R, Casati C, Lozza G, et al. (2000). Interleukin-10 modulates neuronal threshold of vulnerability to ischaemic damage. The European journal of neuroscience, 12: 2265-2272
90. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM (2002). B cells regulate autoimmunity by provision of IL-10. Nature immunology, 3: 944-950
91. Mann MK, Maresz K, Shriver LP, Tan Y, Dittel BN (2007). B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. Journal of immunology (Baltimore, Md.: 1950), 178: 3447-3456
92. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD, et al. (2011). Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. The Journal of neuroscience: the official journal of the Society for Neuroscience, 31: 8556-8563
93. Li HL, Kostulas N, Huang YM, Xiao BG, van der Meide P, Kostulas V, et al. (2001). IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat. Journal of neuroimmunology, 116: 5-14
94. Perez-de Puig I, Miro F, Salas-Perdomo A, Bonfill-Teixidor E, Ferrer-Ferrer M, Marquez-Kisinousky L, et al. (2013). IL-10 deficiency exacerbates the brain inflammatory response to permanent ischemia without preventing resolution of the lesion. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 33: 1955-1966
95. Nayak AR, Kashyap RS, Kabra D, Purohit HJ, Taori GM, Daginawala HF (2012). Time course of inflammatory cytokines in acute ischemic stroke patients and their relation to inter-alfa trypsin inhibitor heavy chain 4 and outcome. Annals of Indian Academy of Neurology, 15: 181-185
96. Astrup J, Siesjo BK, Symon L (1981). Thresholds in cerebral ischemia - the ischemic penumbra. Stroke; a journal of cerebral circulation, 12: 723-725
97. del Zoppo GJ, Sharp FR, Heiss WD, Albers GW (2011). Heterogeneity in the penumbra. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism, 31: 1836-1851
98. Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Torres F, et al. (2006). Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. Journal of neurology, neurosurgery, and psychiatry, 77: 1279-1281
99. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature, 464: 104-107